Products for Research Use Only
RegisterLogin

Lutikizumab

CAT: 0804-HY-P99721-01Size: 1 mgDry Ice: YesHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-P99721-01Size:1 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
Lutikizumab (ABT-981) is an anti-IL-1α and IL-1β dual variable domain immunoglobulin. Lutikizumab binds and inhibits IL-1α and IL-1β. Lutikizumab can be used for the research of osteoarthritis[1].
CAS Number
1791411-57-8
Product Name Alternative
ABT-981
UNSPSC
12352203
Target
Interleukin Related
Type
Inhibitory Antibodies
Related Pathways
Immunology/Inflammation
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/lutikizumab.html
Purity
96.54
Solubility
10 mM in DMSO
Smiles
[Lutikizumab]
Molecular Weight
(196.57 kDa)
References & Citations
[1]Lacy SE, et al. Generation and characterization of ABT-981, a dual variable domain immunoglobulin (DVD-Ig (TM) ) molecule that specifically and potently neutralizes both IL-1α and IL-1β. MAbs. 2015;7 (3) :605-19.
Shipping Conditions
Dry Ice
Storage Conditions
Store at -80°C for 2 years
Scientific Category
Inhibitory Antibodies
Clinical Information
Phase 3

Alternative Products

CatalogName
T77077-01Lutikizumab
GTR18337686-01Lutikizumab Antibody
591988Lutikizumab (IL1A , IL1B)
DHB95502Research Grade Lutikizumab
E55B1207Lutikizumab (Reference antibody)
KBI1450KRIBIOLISA™ Lutikizumab ELISA
GTR18698033-01Lutikizumab Human Monoclonal Antibody
047763IL-1a & IL1b (Lutikizumab) discontinued
C00870Lutikizumab (Anti-IL-1α & IL-1β)
BIO0962SM-5mgAnti-human IL1a & IL1b (Lutikizumab Biosimilar)

Popular Products